1. Pathological study of alpha-chain disease, with special emphasis on evolution
- Author
-
Marie-Jose Lecestre, Caroline Bognel, Annie Galian, Jacques Scotto, Jean-Claude Rambaud, and Claude Matuchansky
- Subjects
Adult ,Male ,Cancer Research ,Pathology ,medicine.medical_specialty ,Lymphoma ,medicine.medical_treatment ,Plasma Cells ,Clone (cell biology) ,Disease ,Immunoglobulin alpha-Chains ,Immunofluorescence ,Diagnosis, Differential ,Bone Marrow ,Laparotomy ,Intestinal Neoplasms ,Intestine, Small ,medicine ,Humans ,Mesentery ,Intestinal Mucosa ,Stage (cooking) ,Pathological ,medicine.diagnostic_test ,business.industry ,Stomach ,Rectum ,Middle Aged ,Prognosis ,Anti-Bacterial Agents ,Clone Cells ,Liver ,Oncology ,Etiology ,Female ,Lymph Nodes ,Immunoglobulin Heavy Chains ,business ,Spleen ,Alpha chain ,Heavy Chain Disease - Abstract
The pathology of six cases of alpha-chain disease (alpha-CD), four of which were followed until complete remission or death, was studied by histologic, immunofluorescence and ultrastructural techniques. The lesions could be classified in three histopographical stages. The late stage C is an immunoblastic sarcoma probably deriving from the same clone as the initial plasmacytic stage A, stage B being a transitional one between A and C. The asynchronism of the lesions in different organs in the same patient requires a laparotomy for an accurate staging which determines the prognosis and the treatment. Complete and prolonged remissions have been observed at stage A only, sometimes with oral antibiotic treatment alone. At all stages, alpha-CD and the "Mediterranean lymphoma" share identical aetiological, clinical and pathological features. Accurate immunological studies will determine the precise-frequency of alpha-CD protein synthesis in the latter syndrome.
- Published
- 1977